Home » ENTREMED RAISES $30 MILLION IN PRIVATE PLACEMENT
ENTREMED RAISES $30 MILLION IN PRIVATE PLACEMENT
EntreMed, Inc, a clinical-stage pharmaceutical company developing therapeutics
for the treatment of cancer and inflammatory diseases, today announced that
it has entered into definitive agreements with institutional investors for the
private placement of units consisting of shares of common stock and warrants
at a purchase price of $2.3125 per unit. In connection with the placement, the
Company will issue approximately 13 million shares of its common stock and warrants
to purchase up to 6.5 million additional shares of common stock at an exercise
price of $2.50 per share.
Yahoo
News
KEYWORDS FDAnews Drug Daily Bulletin
Upcoming Events
-
07May
-
14May
-
30May